Valeo Financial Advisors, LLC Phio Pharmaceuticals Corp. Transaction History

Valeo Financial Advisors, LLC

  • $3.81 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 22, 2021
SELL
$1.87 - $2.8 $7,480 - $11,200
-4,000 Closed
0 $0
Q1 2021

Apr 12, 2021
BUY
$2.48 - $4.05 $9,920 - $16,200
4,000 New
4,000 $11,000
Q3 2020

Oct 28, 2020
SELL
$1.95 - $2.94 $487 - $735
-250 Closed
0 $0
Q2 2020

Jul 20, 2020
BUY
$1.68 - $3.05 $420 - $762
250 New
250 $1,000

Others Institutions Holding PHIO

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About Phio Pharmaceuticals Corp.

PHIO Quotes by TradingView
  • Ticker PHIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,658,700
  • Market Cap $34.4M
  • Description
  • Phio Pharmaceuticals Corp. develops immuno-oncology therapeutics in the United States. It offers INTASYL therapeutic platform focuses on targeting tumor and immune cells by regulating genes of the immune system. The company develops PH-762 that activates immune cells to recognize and kill cancer cells by reducing the expression of the checkpoint...
More about PHIO
Track This Portfolio

Track Valeo Financial Advisors, LLC Portfolio

Follow Valeo Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Valeo Financial Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email